METTL3-Mediated m6A Modification Regulates the Osteogenic Differentiation through LncRNA CUTALP in Periodontal Mesenchymal Stem Cells of Periodontitis Patients

Xin Chen,Yuan Qin,Xian Wang,Hao Lei,Xiaochen Zhang,Houzhuo Luo,Changgang Guo,Weifu Sun,Shishu Fang,Wen Qin,Zuolin Jin
DOI: https://doi.org/10.1155/2024/3361794
2024-01-19
Stem Cells International
Abstract:Objective. Periodontitis is a chronic inflammatory disease that causes loss of periodontal support tissue. Our objective was to investigate the mechanism by which METTL3-mediated N6-methyladenosine modification regulates the osteogenic differentiation through lncRNA in periodontal mesenchymal stem cells in patients with periodontitis (pPDLSCs). Material and Methods. We carried out a series of experiments, including methylated RNA immunoprecipitation-PCR, quantitative real-time polymerase chain reaction, and western blotting. The expressions of alkaline phosphatase (ALP), Runx2, Col1, Runx2 protein level, ALP staining, and Alizarin red staining were used to demonstrate the degree of osteogenic differentiation. Results. We found that METTL3 was the most significantly differentially expressed methylation-related enzyme in pPDLSCs and promoted osteogenic differentiation of pPDLSCs. METTL3 regulated the stability and expression of lncRNA CUTALP, while lncRNA CUTALP promoted osteogenic differentiation of pPDLSCs by inhibiting miR-30b-3p. At different time points of osteogenic differentiation, lncRNA CUTALP expression was positively correlated with Runx2, while miR-30b-3p showed the opposite pattern. The attenuated osteogenic differentiation induced by METTL3 knockdown was recovered by lncRNA CUTALP overexpression. The attenuated osteogenic differentiation induced by lncRNA CUTALP knockdown could be reversed by the miR-30b-3p inhibitor. Conclusions. In summary, METTL3/lncRNA CUTALP/miR-30b-3p/Runx2 is a regulatory network in the osteogenic differentiation of pPDLSCs.
cell & tissue engineering
What problem does this paper attempt to address?
The problem this paper attempts to address is: exploring how METTL3-mediated N6-methyladenosine (m6A) modification regulates osteogenic differentiation in periodontal ligament stem cells (pPDLSCs) of periodontitis patients through long non-coding RNA (lncRNA). Specifically, the researchers aim to solve this problem through the following aspects: 1. **Expression and function of METTL3 in pPDLSCs**: The researchers first detected the expression level of METTL3 in pPDLSCs and found it to be significantly lower than in normal periodontal ligament stem cells (hPDLSCs). Through overexpression and knockdown experiments, the researchers verified the impact of METTL3 on the osteogenic differentiation of pPDLSCs. 2. **Screening and identification of lncRNA CUTALP**: Through microarray analysis and MeRIP-qPCR experiments, the researchers screened for differentially methylated lncRNAs in pPDLSCs and identified lncRNA CUTALP as a key regulatory factor. 3. **Regulation of lncRNA CUTALP expression and stability by METTL3**: The researchers confirmed through RNA stability experiments and RIP-qPCR experiments that METTL3 regulates osteogenic differentiation by promoting the expression and stability of lncRNA CUTALP. 4. **Regulatory mechanism of lncRNA CUTALP on osteogenic differentiation**: The researchers further explored the role of lncRNA CUTALP in osteogenic differentiation and found that it promotes osteogenic differentiation by competitively binding to miR-30b-3p to inhibit the expression of osteogenic differentiation inhibitors. In summary, this paper aims to reveal the molecular mechanism by which METTL3-mediated m6A modification regulates osteogenic differentiation in pPDLSCs through lncRNA CUTALP, providing new targets and ideas for the treatment of periodontitis.